Trial intelligence / Profile preview

STEROSENS: Steroid Replacement and Insulin Sensitivity in Hypogonadal Men

NCT02847806Phase 3Completed

Sponsor
CHU Caen Normandie
Start
Jan 2008
Primary completion
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of estradiol, testosterone in Hypogonadism, sponsored by CHU Caen Normandie. Started Jan 2008; status: completed.

02

Drugs

estradioltestosterone
03

Conditions

Hypogonadism

Beyond the preview

Go deeper on NCT02847806.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02847806.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call